Cal-Maine Foodsの空売り状況は、投資家がCal-Maine Foodsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Cal-Maine Foods (NASDAQ:CALM) 株価情報, 空売り情報

Cal-Maine Foods

Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.

Cal-Maine Foods Inc

Calmare Therapeutics Inc

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Coty Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>)</h3>
<ul>
<li>On Feb. 10, Coty missed second-quarter earnings and revenue estimates. Sue Nabi, Coty&#8217;s CEO, said, &#8220;As we are now midway through our fiscal year, it is clear that FY25 is shaping up to be a pivotal year. On the one hand, the global beauty market continues to grow at a healthy pace, even if growth has moderated off of the elevated levels of the last few years, which benefited from more material pricing increases. And in this backdrop, fragrances of all price points continue to outperform most other beauty categories, which strongly benefits Coty&#8217;s business as fragrances account for over 60% of our revenues and an even bigger portion of our profits." The company's stock fell around 23% over the past month and has a <a href="https://www.benzinga.com/quote/COTY">52-week low of $5.54</a>.</li>
<li>RSI Value: 21.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>COTY Price Action: Shares of Coty fell 3% to close at $5.58 on Friday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021825&amp;t=be2bearmibe3na1">COTY news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="862" height="783" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042534/image-148.png" alt="" class="wp-image-786413" style="width:609px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042534/image-148.png 862w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042534/image-148-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042534/image-148-768x698.png 768w" sizes="(max-width: 862px) 100vw, 862px" /></a></figure>
<h3 class="wp-block-heading">elf Beauty Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Feb. 6, e.l.f. Beauty reported quarterly earnings of 74 cents per share, which met the analyst consensus estimate and is unchanged from the same period last year. Quarterly revenue came in at $355.32 million, which beat the analyst consensus estimate of $329.67 million and is an increase over sales of $270.94 million from the same period last year. The company's stock fell around 38% over the past month and <a href="https://www.benzinga.com/quote/ELF">has a 52-week low</a> of $63.50.</li>
<li>RSI Value: 15.4</li>
<li>ELF Price Action: Shares of elf Beauty fell 2.6% to close at $73.00 on Friday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021825&amp;t=be2bearmibe3na1">ELF stoc</a>k. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="877" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042554/image-2-45.png" alt="" class="wp-image-786414" style="width:717px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042554/image-2-45.png 877w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042554/image-2-45-300x286.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042554/image-2-45-768x733.png 768w" sizes="(max-width: 877px) 100vw, 877px" /></a></figure>
<h3 class="wp-block-heading">Cal-Maine Foods Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>)</h3>
<ul>
<li>On Feb. 3, Cal-Maine Foods announced the acquisition of Feed Mill Operations in North Carolina. The company's stock fell around 17% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/CALM">low of $54.88.</a></li>
<li>RSI Value: 27.5</li>
<li>CALM Price Action: Shares of Cal-Maine fell 1.1% to close at $279.45 on Wednesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021825&amp;t=be2bearmibe3na1">CALM shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="848" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042729/image-149.png" alt="" class="wp-image-786418" style="width:653px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042729/image-149.png 848w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042729/image-149-300x296.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042729/image-149-768x758.png 768w" sizes="(max-width: 848px) 100vw, 848px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43730195/top-3-defensive-stocks-that-may-collapse-in-q1">Top 3 Defensive Stocks That May Collapse In Q1</a></li>
</ul>

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

CALM

COTY

Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter

As inflation rises, grocery stocks have emerged as major beneficiaries, particularly those <a href="https://www.benzinga.com/25/02/43709413/egg-prices-hit-record-highs-new-york-bodegas-get-creative-and-sell-three-packs-for-299">tied to egg production</a>. 
The price of eggs has skyrocketed due to supply constraints, sending shares of Vital Farms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VITL#NASDAQ">VITL</a>) up 154% and Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) up 90% over the past year. We will discuss more on that later, but before that, let us see how investors looking to capitalize on these trends can consider <a href="https://www.benzinga.com/etfs">ETFs with significant exposure</a> to the aforementioned stocks and the food industry in general, such as the Invesco Food &amp; Beverage ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBJ#NYSE">PBJ</a>) and the Invesco S&amp;P SmallCap Consumer Staples ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSCC#NASDAQ">PSCC</a>).
The Invesco Food &amp; Beverage ETF offers exposure to companies engaged in food production, distribution, and retail. It holds leading names in the food industry, including packaged food manufacturers and grocery retailers. With a focus on consumer staples, PBJ provides investors with a diversified approach to food sector investing, helping them capitalize on rising grocery prices while mitigating risks associated with individual stocks. Companies such as Vital Farms, and PepsiCo are among its top holdings.
Also Read: <a href="https://www.benzinga.com/25/02/43709413/egg-prices-hit-record-highs-new-york-bodegas-get-creative-and-sell-three-packs-for-299">Egg Prices Hit Record Highs, New York Bodegas Get Creative And Sell Three Packs For $2.99</a>
The ETF's allocation to food manufacturers and retailers ensures it benefits from higher food prices. The recent surge in egg prices, along with elevated costs for other breakfast staples like orange juice and coffee, positions this ETF well for continued growth. The price of the ETF has surged around 2% in the past 5 days.
The Invesco S&amp;P SmallCap Consumer Staples ETF focuses on small-cap consumer staples companies, including food producers and distributors. Given that smaller food companies can experience outsized gains during price surges, this ETF is an attractive option for investors looking to capture high-growth opportunities in the grocery sector.
Key Holdings include Cal-Maine Foods and Vital Farms, both of which have seen explosive stock price growth amid the egg price spike.
With its targeted exposure to smaller, high-growth food companies, PSCC offers a direct way to invest in the ongoing food inflation trend. The ETF stands to benefit from continued price increases in essential grocery items, making it a compelling choice in the current market environment.
<h3 class="wp-block-heading">Egg Price Surge And Inflation Impact</h3>
Inflation in the U.S. <a href="https://in.benzinga.com/25/02/43663963/record-high-egg-prices-drive-inflation-higher-in-january">picked up in January</a>, driven by higher grocery, gasoline, and rent prices. The Consumer Price Index (CPI) grew 3% year over year, up from December's 2.9%, marking the highest increase since June. 
Monthly, the index rose 0.5%, the largest uptick since August 2023.
Among the key drivers of inflation were food prices, with grocery costs rising 0.3% in December following a 0.5% increase in November. Notably, egg prices soared 15.2% from December and 53% from the prior year, the steepest increase since June 2015. This surge—attributed to adverse weather and bird flu outbreaks—has led to significant gains for egg producers.
As food inflation accelerates, ETFs like PBJ and PSCC offer investors a way to gain exposure to grocery stocks poised to benefit from these trends.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/02/43737539/tesla-vs-ford-new-defiance-etf-capitalized-on-market-disruptors">Tesla Vs. Ford: New Defiance ETF Capitalized On Market Disruptors</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Broad U.S. Equity ETFs

ETFs

MAGS

PSCC

VITL

ETFs Benefit From Egg-Straordinary Surge In Grocery Prices

WIIM

Cal-Maine Foods shares are trading lower after Zoetis announced it received a conditional USDA license for an avian influenza vaccine for chickens.

Watching Cal-Maine Foods; Shares Move Lower After Zoetis Announced It Received Conditional License From USDA For Avian Influenza Vaccine For Chickens

Egg prices have soared in recent months and stores are taking action to limit purchases in the wake of rising bird flu cases that could see costs <a href="https://www.benzinga.com/general/health-care/25/01/43372753/eggs-prices-soar-as-bird-flu-spreads-why-experts-expect-another-45-increase-in-2025">continue to rise.</a>
What Happened: The cost of eggs was up 15.2% in the<a href="https://www.benzinga.com/25/02/43663963/record-high-egg-prices-drive-inflation-higher-in-january"> month of January,</a> the largest increase since June 2015, which made the food item one of the biggest factors of rising inflation in the latest CPI report.
A dozen eggs costs $4.95 nationwide on average and the U.S. Department of Agriculture predicts the cost could rise another 45% in 2025 as bird flu cases rise.
Retailers including Costco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>), Trader Joe's and Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) are limiting the number of eggs that consumers can buy in the wake of the surging prices and limited supplies, as <a href="https://abcnews.go.com/US/grocery-stores-limit-egg-purchases-thefts-increase-bird-flu/story?id=118732180">reported </a>by ABC News.
Bodegas in New York are taking matters into their own hands to offer a solution to consumers who need to buy a few eggs at a time and can't afford the $10+ cost per dozen eggs in the state.
Pamela's Green Deli in the Bronx is selling "loosie"-style eggs, similar to selling single cigarettes, to consumers, as <a href="https://nypost.com/2025/02/12/us-news/nyc-bodegas-selling-loosie-eggs-as-prices-of-cartons-skyrocket/">reported </a>by the New York Post.
"These people don't have enough money to buy a dozen eggs, so I have to sell them separately," Pamel's Green Deli owner Fernando Rodriguez told the Post. "When I saw how high the price of eggs has become, we decided to break it down into small bags."
Rodriguez said the store previously sold a dozen eggs for $2.49 before the recent spikes related to bird flu. A plastic bag of three eggs now sells for $2.99 at the store.
The store, which serves a large number of low-income consumers, is seeing demand for the loosies over buying a dozen eggs at a time. Rodriguez said around one-third of the store's customers are buying the three packs rather than the dozen eggs.
Rodriguez, who is from the Dominican Republic, said that his home country used to sell single eggs. "I know how difficult it is for families to afford eggs and milk."
Other bodegas are catching on to the practice and using the same method. According to the report, selling cigarettes individually is illegal and selling eggs out of the dozen could also be a potential illegal practice.
Read Also: <a href="https://www.benzinga.com/25/02/43667841/inflation-is-hot-and-getting-hotter">Inflation Runs Hot In January: &#8216;Houston We Have A Problem,&#8217; Experts Warn</a>
Why It's Important: The USDA reports that 150 million poultry birds have been killed since 2022 as bird flu continues to spread across the country. The spike in bird flu is leading to less egg-producing birds and causing shortages.
The number of poultry birds killed has risen in recent months with seven million in November, 18 million in December and 23 million in January.
On Wednesday, the state of Ohio reported its first human case of bird flu with a farm worker in Mercer County being infected. There have been 68 human cases of bird flu in 11 states since 2024, as <a href="https://www.usatoday.com/story/news/health/2025/02/13/bird-flu-ohio-first-human-case/78510403007/">reported </a>by USA Today.  
People who work with poultry, dairy cows and waterfowl are most at risk of becoming infected with bird flu, like the Ohio worker.
Cal-Maine Foods Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>), the nation's largest egg producer is likely to come under pressure as egg prices rise. The company's recent second-quarter financial results saw revenue of $954.7 million significantly beat a Street consensus estimate of $751.5 million.
The company has beaten analyst estimates for earnings per share and revenue in four straight quarters according to data <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021325&amp;t=be2bearmibe3na1">from Benzinga Pro</a>. The better-than-expected results come as the cost of eggs have soared for consumers.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/25/02/43667632/inflation-rises-in-january-housing-costs-up-adding-to-consumers-2025-concerns">Inflation Rises In January, Housing Costs Up, Adding To Consumers&#8217; 2025 Concerns</a></li>
</ul>

COST

Egg Prices Hit Record Highs, New York Bodegas Get Creative And Sell Three Packs For $2.99

January's inflation data came in hotter-than-expected Wednesday morning with the cost of groceries rising again, due in part to a jump in <a href="https://www.benzinga.com/general/restaurants/25/02/43511263/high-egg-prices-drive-waffle-house-to-add-50-cent-surcharge">the price of eggs.&nbsp;</a>
What To Know: The average price of a dozen eggs reached a record-high of $4.95 last month, rising 15.2% and contributing to a 0.5% increase in the cost of food at home.&nbsp;
Charlie Billelo, chief market strategist for Creative Planning, highlighted the 238% jump in the average price of a dozen eggs as the largest 4-year increase in history.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The price of a dozen eggs in the US spiked to a new record high of $4.95 in January. Over the last 4 years, egg prices have increased 238%, the largest 4-year increase in history.<a href="https://t.co/rQuXrxVpWs">https://t.co/rQuXrxVpWs</a> <a href="https://t.co/FbGPbHNIBG">pic.twitter.com/FbGPbHNIBG</a>
&mdash; Charlie Bilello (@charliebilello) <a href="https://twitter.com/charliebilello/status/1889682939690070276?ref_src=twsrc%5Etfw">February 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read More: <a href="https://www.benzinga.com/government/regulations/25/02/43656846/inflation-rises-more-than-expected-in-january-chills-interest-rate-cut-hopes">Inflation Rises More Than Expected In January, Chills Interest Rate Cut Hopes</a>
Data from the U.S. Department of Agriculture shows that a record number of more than 20 million egg-laying chickens died in the last quarter due to the H5N1 bird flu. Bill Adams, Chief Economist for Comerica Bank, pointed to the bird flu as <a href="https://www.benzinga.com/general/health-care/25/01/43372753/eggs-prices-soar-as-bird-flu-spreads-why-experts-expect-another-45-increase-in-2025">the cause</a> of the jump in egg prices.&nbsp;&nbsp;
"The H5N1 bird flu sweeping through the U.S. agriculture industry is forcing farmers to cull infected birds and sending egg prices soaring, a big supply-side shock to food prices. Whole fresh chicken prices rose 1.0% on the month, too," Adams said.&nbsp;
Interestingly, egg producers are reporting record profits as the avian flu spreads while consumers pay higher prices.&nbsp;
Cal-Maine Foods Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>), the nation&#8217;s largest egg producer, reported<a href="https://www.benzinga.com/news/earnings/25/01/42862269/cal-maine-foods-stock-climbs-after-strong-q2-results-eps-beat-revenues-beat"> its most recent </a>quarterly revenue at $954.7 million, well above the $751.49 million consensus estimate.
The USDA predicts egg prices <a href="https://www.ers.usda.gov/data-products/food-price-outlook/summary-findings#:~:text=In%202025,%20prices%20for%20all,of%20-2.7%20to%205.5%20percent.%5C">will </a>rise another 45% in 2025 and Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">POL</a>) -based prediction platform Polymarket even has a <a href="https://polymarket.com/event/price-of-dozen-eggs-in-february?tid=1739374205612">prediction market</a> on the price of eggs in February. The highest odds are at 25% for the price to be between $5.50 and $5.75 a dozen.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">While everyone is complaining about the inflation report, your refrigerator could look like this if you correctly predict how much prices will rise. <a href="https://t.co/xTovIBuiDp">pic.twitter.com/xTovIBuiDp</a>
&mdash; Polymarket (@Polymarket) <a href="https://twitter.com/Polymarket/status/1889686175020970332?ref_src=twsrc%5Etfw">February 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/02/43535256/palantir-adds-elon-musks-ai-chatbot-grok-to-aip">Palantir Adds Elon Musk&#8217;s AI Chatbot Grok To AIP</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Econ #s

Economics

General

$POL

Record-High Egg Prices Drive Inflation Higher In January

Investors might want to bet on Cal-Maine Foods (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calm#NASDAQ">CALM</a>), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The Zacks rating relies solely on a company&#39;s changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.
The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real-time.
As such, the Zacks rating upgrade for Cal-Maine is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
<h2>Most Powerful Force Impacting Stock Prices</h2>
The change in a company&#39;s future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company&#39;s shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Cal-Maine imply an improvement in the company&#39;s underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
<h2>Harnessing the Power of Earnings Estimate Revisions</h2>
As empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see <a href="https://www.zacks.com/stocks/buy-list/?ADID=zp_1link&amp;ICID=zpi _1link" target="_blank">the complete list of today&#39;s Zacks #1 Rank (Strong Buy) stocks here &gt;&gt;&gt;&gt;</a>.
<h2>Earnings Estimate Revisions for Cal-Maine</h2>
This egg producer is expected to earn $15.59 per share for the fiscal year ending May 2025, which represents a year-over-year change of 174%.
Analysts have been steadily raising their estimates for Cal-Maine. Over the past three months, the Zacks Consensus Estimate for the company has increased 82.6%.
<h2>Bottom Line</h2>
Unlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of &#39;buy&#39; and &#39;sell&#39; ratings for its entire universe of more than 4000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a &#39;Strong Buy&#39; rating and the next 15% get a &#39;Buy&#39; rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn <a href="https://www.zacks.com/education/stock-education/zacks-rank-guide" target="_blank">more about the Zacks Rank here &gt;&gt;&gt;</a>
The upgrade of Cal-Maine to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
<h2>7 Best Stocks for the Next 30 Days</h2>
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers &quot;Most Likely for Early Price Pops.&quot;
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention.&nbsp;
<a href="https://www.zacks.com/registration/ultimatetrader/welcome/eoffer/4e87?add=1473&amp;adid=SYND_BENZ_ZU_7BESTREPORTA_TALEOFTAPE_523_02062025_2411437&amp;cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2411437" style="font-weight:bold">See them now &gt;&gt;</a>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. <a href="https://www.zacks.com/registration/pfp/?ALERT=RPT_7BST_LP194&amp;ADID=SYND_BENZ_7BEST_TALEOFTAPE_523_2411437&amp;cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2411437" target="_blank">Click to get this free report</a> 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=CALM&amp;ADID=SYND_BENZ_TCK_TALEOFTAPE_523_2411437_CALM&amp;cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2411437">Cal-Maine Foods, Inc. (NASDAQ: </a><a class="ticker" href="https://www.benzinga.com/stock/calm#NASDAQ">CALM</a>): Free Stock Analysis Report
<a href="https://www.zacks.com/stock/news/2411437/all-you-need-to-know-about-cal-maine-calm-rating-upgrade-to-strong-buy?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2411437">To read this article on Zacks.com click here.</a>
<a href="https://www.zacks.com/">Zacks Investment Research</a>
Photo via Shutterstock

Upgrades

Analyst Ratings

All You Need To Know About Cal-Maine (CALM) Rating Upgrade To Strong Buy

As egg prices soar due to shortages caused by the bird flu, a new warning signal is flashing red: Waffle House has added a 50-cents-per-egg <a href="https://www.benzinga.com/general/health-care/25/01/43372753/eggs-prices-soar-as-bird-flu-spreads-why-experts-expect-another-45-increase-in-2025">surcharge to its menu items. </a>
What To Know: Waffle House is known for its emergency preparedness and ability to deliver 24-hour, 365-day service, even under extreme conditions. FEMA unofficially uses the "Waffle House Index" to inform disaster responses and when the Waffle House makes adjustments, it might be time to pay attention.
Waffle House pointed to the impact of ongoing egg shortages and rising prices caused by bird flu as the reason for its new 50 cent egg surcharge.&nbsp;
Read Next: <a href="https://www.benzinga.com/25/02/43474797/amazon-faces-trumps-tariffs">Amazon &#8216;Relatively Well-Positioned&#8217; To Face Trump&#8217;s Tariffs: Analyst</a>&nbsp;
"While we hope these price fluctuations will be short-lived we cannot predict how long this shortage will last," the company told Reuters.&nbsp;
According to the U.S. Department of Agriculture, the wholesale cost for a dozen eggs in the Midwest is $7.08, nearly seven times the price from two years ago. WholeFoods in New York City sells a dozen cage-free eggs for $11.99.&nbsp;
What Else: Eggs are so expensive that a $40,000 theft was reported over the weekend by Pete &amp; Gerry's Organics in Antrim Township, Pennsylvania. About 100,000 organic eggs were reportedly taken from the back of a distribution trailer, according to a CBS News <a href="https://www.cbsnews.com/news/stolen-eggs-pennsylvania-pete-and-gerry-farm/">report</a>.&nbsp;
The Pennsylvania State police are investigating but have not released any information on potential suspects or circumstances surrounding the theft.&nbsp;
Kalshi even has a<a href="https://kalshi.com/markets/kxeggs/egg-prices"> betting market</a> on egg prices that shows a 79% chance that egg prices will go up during President Donald Trump's first month in office.&nbsp;
What's Going On: The bird flu outbreak is behind the current egg shortages and high prices look to continue with no relief in sight. The USDA<a href="https://www.ers.usda.gov/data-products/food-price-outlook/summary-findings#:~:text=In%202025,%20prices%20for%20all,of%20-2.7%20to%205.5%20percent.%5C"> predicts</a> egg prices will rise another 45% in 2025 due in large part to the bird flu ravaging commercial flocks.
Data from USDA shows that a record number of more than 20 million egg-laying chickens died in the last quarter due to bird flu. Last week the second-largest egg producer in the U.S., Rose Acre Farms confirmed its chickens had tested positive for bird flu, likely extending the period of high egg prices and shortages.&nbsp;
Stocks To Watch: Egg producers are reporting record profits during the ongoing bird flu outbreak, however.&nbsp;
Cal-Maine Foods Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) , the nation&#8217;s largest egg producer, recently blew estimates out of the water with quarterly revenue of $954.7 million, well above the $751.49 million analyst estimate.
Cal-Maine Foods stock has gained more than 90% over the past year.&nbsp;
Another stock to watch is Vital Farms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VITL#NASDAQ">VITL</a>), a smaller producer specializing in pasture-raised eggs. Telsey Advisory Group analyst Sarang Vora recently said he sees the company's sales growing at an annual growth rate of 19% to 20% and hitting the $1 billion mark in 2027.&nbsp;
Vital Farms stock is up nearly 150% over the past year.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/02/43468887/robert-f-kennedy-nomination-advances-to-full-senate-vaccine-stocks-drop">Robert F. Kennedy&#8217;s Health Secretary Nomination Advances To Full Senate: Vaccine Stocks Drop&nbsp;</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Retail Sales

Restaurants

High Egg Prices Drive Waffle House To Add 50-Cent Surcharge

Reported Earlier, Cal-Maine Foods Acquires Two Feed Mills, Strengthening Production Efficiency

Shares of egg producer Cal-Maine Foods are trading lower. Weakness may be due to uncertainty regarding bird flu concerns.

Egg prices in the U.S. have risen 60% over the past year, due in large part to the bird flu ravaging commercial flocks. Here's a look at why experts see the<a href="https://www.benzinga.com/general/biotech/25/01/43117087/bird-flu-update-first-commercial-case-in-georgia-moderna-receives-590-million-to-develop-vaccine"> prices continuing to climb.</a> 
The Details: The average price for a dozen large, grade-A eggs rose 60% over the past year, reaching $4.15 in December, according <a href="https://data.bls.gov/timeseries/APU0000708111">to data</a> from the Bureau of Labor Statistics. The USDA predicts egg prices <a href="https://www.ers.usda.gov/data-products/food-price-outlook/summary-findings#:~:text=In%202025,%20prices%20for%20all,of%20-2.7%20to%205.5%20percent.%5C">will </a>rise another 45% in 2025 due to a strain of bird flu known as H5N1 that killed 13.2 million commercial egg-laying hens in December.
Read Next: <a href="https://www.benzinga.com/general/travel/25/01/43343648/all-60-passengers-4-crew-members-onboard-american-airlines-jet-feared-dead-after-midair-collision-official-says">64 Killed In American Airlines Midair Collision Near D.C., Worst US Air Disaster Since 2001&nbsp;</a>
On top of the record-high prices, consumers are also facing egg shortages and purchase limits at major retailers like Costco Wholesale Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) and Albertsons Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>). 
Data from the U.S. Department of Agriculture shows that a record number of more than 20 million egg-laying chickens died in the last quarter due to bird flu.&nbsp;
In an attempt to contain the virus, farmers are compensated for chickens and eggs that are destroyed through a USDA program which said it had paid out $1.25 billion to farmers since the outbreak started in 2022, according to a CBS News <a href="https://www.cbsnews.com/news/egg-industry-chicken-deaths-bird-flu/">report</a>.&nbsp;
In fact, egg producers are reporting record profits during the latest bird flu outbreak. Cal-Maine Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NYSE">CALM</a>), the nation's largest egg producer, reported<a href="https://www.benzinga.com/news/earnings/25/01/42862269/cal-maine-foods-stock-climbs-after-strong-q2-results-eps-beat-revenues-beat"> its most recent </a>quarterly revenue at $954.7 million, well above the $751.49 million consensus estimate.
The company attributed its high revenue in part to restricted supply resulting from bird flu outbreaks. Cal-Maine Foods stock has gained more than 75% over the past six months.&nbsp;
Telsey Advisory Group analyst Sarang Vora initiated coverage this week on Vital Farms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VITL#NASDAQ">VITL</a>), a smaller producer specializing in pasture-raised eggs. Vora said he sees the company&#8217;s sales growing at an annual growth rate of 19% to 20% and hitting the $1 billion mark in 2027, versus $600 million in 2024. 
This week, Rose Acre Farms, the second-largest egg producer in the U.S., confirmed its chickens had tested positive for bird flu, likely extending the period of high egg prices and shortages. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43320124/microsoft-shares-slide-after-q2-results-cloud-revenue-misses-expectations-details">Microsoft Shares Slide After Q2 Results, Cloud Revenue Misses Expectations: Details</a>&nbsp;</li>
</ul>
Image: Shutterstock

Health Care

Eggs Prices Soar As Bird Flu Spreads: Why Experts Expect Another 45% Increase In 2025

According to the latest data from the Centers for Disease Control and Prevention, the current bird flu outbreak has caused 67 human cases of bird flu in the U.S. and one death associated with the virus. The virus was confirmed on Friday at a commercial poultry production facility in Georgia, the nation's top state <a href="https://www.benzinga.com/general/biotech/25/01/43046294/bird-flu-raising-red-flags-among-health-officials-cdc-urges-faster-testing">for chicken production. </a>
What To Know: The CDC said that the current public health risk is low and the agency is watching the situation carefully and monitoring people with animal exposures. Bird flu is "widespread in wild birds worldwide and is causing outbreaks in poultry and U.S. dairy cows with several recent human cases in U.S. dairy and poultry workers," the CDC stated in its <a href="https://www.cdc.gov/bird-flu/situation-summary/index.html">most recent</a> update.&nbsp;
On Friday, the Georgia Department of Agriculture announced it <a href="https://agr.georgia.gov/avian-influenza">detected</a> a case of Highly Pathogenic Avian Influenza at a commercial poultry producer in the state. The case marks the first in Georgia, the nation's top state for chicken production, since the 2022 countrywide outbreak. 
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/01/43106379/trump-reverses-bidens-ai-policies-on-day-1-what-it-means-for-tech-giants-nvidia-amd-alphabet">Trump Reverses Biden&#8217;s AI Policies On Day 1: What It Means For Tech Giants Nvidia, AMD, Alphabet&nbsp;</a>
"This is a serious threat to Georgia's #1 industry and the livelihoods of thousands of Georgians who make their living in our state's poultry industry," Georgia Agriculture Commissioner Tyler Harper said in a news release.&nbsp;
According to an AP News<a href="https://apnews.com/article/bird-flu-georgia-chicken-commercial-flock-a5bcad4662d4cf60212f6acb4a55d2ad"> report,</a> the bird flu virus has been detected in 84 commercial and backyard flocks in the past month with 10.7 million birds affected. The virus has also been confirmed in dozens of dairy farms.
What Else: On Friday, Moderna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) announced <a href="https://www.benzinga.com/general/biotech/25/01/43105845/why-is-moderna-stock-trading-higher-on-tuesday-2">it received</a> an additional $590 million award from the U.S. Department of Health and Human Services (HHS) to accelerate the development of its mRNA-based influenza vaccines, including bird flu.
In 2023, Moderna commenced a Phase 1/2 study to generate safety and immunogenicity data for an investigational pandemic influenza vaccine (mRNA-1018) candidate against the H5 and H7 avian influenza viruses. Based on the preliminary data from the Phase 1/2 study, Moderna is preparing to advance mRNA-1018 into Phase 3. 
Other pharmaceutical companies, including Novavax Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>), have bird flu vaccine candidates currently in clinical trials. 
CureVac BV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVAC#NASDAQ">CVAC</a>) started a phase I/II study on its bird flu vaccine candidate developed in collaboration with GSK plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>). 
Egg producer Cal-Maine Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NYSE">CALM</a>) reported<a href="https://www.benzinga.com/news/earnings/25/01/42862269/cal-maine-foods-stock-climbs-after-strong-q2-results-eps-beat-revenues-beat"> its most recent </a>quarterly revenue of $954.7 million, well above the  $751.49 million consensus estimate, due in part to restricted supply resulting from highly pathogenic avian influenza (HPAI) outbreaks. Cal-Maine Foods stock gained more than 75% over the past six months. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/initiation/25/01/43102452/roku-analyst-sees-25-upside-as-tv-ad-dollars-go-digital">Roku Analyst Sees 25% Upside As TV Ad Dollars Go Digital&nbsp;</a></li>
</ul>
Photo: Shutterstock

Biotech

Equities

Government

CVAC

MRNA

NVAX

Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>)</h3>
<ul>
<li>Dividend Yield: 5.57%</li>
<li>TD Cowen analyst Robert Moskow maintained a Hold rating and cut the price target from $34 to $32 on Jan. 8, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Evercore ISI Group analyst David Palmer downgraded the stock from Outperform to In-Line and lowered the price target from $38 to $35 on Jan. 7, 2025. This analyst has an accuracy rate of 62%.</li>
<li>Recent News: On Oct. 30, Kraft Heinz posted third-quarter earnings of 75 cents per share, beating estimates, but reported a revenue decline and anticipates a prolonged recovery in U.S. retail.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011525&amp;t=be2bearmibe3na1">KHC news</a>. </li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011525&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/8218ab9a-9e7e-4522-8375-228aba88a427" alt="" style="width:579px;height:auto" /></a></figure>
<h3 class="wp-block-heading">Conagra Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>)</h3>
<ul>
<li>Dividend Yield: 5.37%</li>
<li>JP Morgan analyst Ken Goldman maintained a Neutral rating and cut the price target from $30 to $29 on Jan. 3, 2025. This analyst has an accuracy rate of 77%.</li>
<li>B of A Securities analyst Bryan Spillane maintained a Neutral rating and cut the price target from $31 to $29 on Dec. 20, 2024. This analyst has an accuracy rate of 62%.</li>
<li>Recent News: On Dec. 19, the company reported second-quarter adjusted earnings per share of 70 cents, beating the analyst consensus estimate of 67 cents.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011525&amp;t=be2bearmibe3na1">CAG news</a> </li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011525&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/14824195-75d1-4a55-84bb-390b41a774b5" alt="" style="width:652px;height:auto" /></a></figure>
<h3 class="wp-block-heading">Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>)</h3>
<ul>
<li>Dividend Yield: 3.89%</li>
<li>Goldman Sachs analyst Adam Samuelson maintained a Sell rating and raised the price target from $47 to $52 on July 17, 2024. This analyst has an accuracy rate of 60%.</li>
<li>Stephens &amp; Co. analyst Ben Bienvenu reiterated an Equal-Weight rating with a price target of $65 on April 3, 2024. This analyst has an accuracy rate of 75%.</li>
<li>Recent News: On Jan. 7, Cal-Maine Foods reported better-than-expected quarterly EPS and revenues.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011525&amp;t=be2bearmibe3na1">CALM news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011525&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="917" height="835" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/15071438/image-97.png" alt="" class="wp-image-734513" style="width:619px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/15071438/image-97.png 917w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/15071438/image-97-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/15071438/image-97-768x699.png 768w" sizes="(max-width: 917px) 100vw, 917px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/42992639/how-to-earn-500-a-month-from-state-street-stock-ahead-of-q4-earnings">How To Earn $500 A Month From State Street Stock Ahead Of Q4 Earnings</a></li>
</ul>

Dividends

Price Target

Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields

U.S. stocks were lower, with the Dow Jones index falling over 150 points on Wednesday.
Shares of AAR Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) rose sharply during Tuesday's session after posted stronger-than-expected <a href="https://www.benzinga.com/news/earnings/25/01/42862022/aar-shares-climb-on-better-than-expected-q2-results-details">second-quarter results.</a>
The company reported quarterly earnings of 90 cents per share, which beat the analyst consensus estimate of 84 cents. Quarterly revenue came in at $686.1 million, which beat the analyst consensus estimate of $654.18 million.
AAR shares jumped 9.6% to $67.67 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Sana Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>) shares jumped 249% to $5.77 after the company on Tuesday announced clinical trial results from its type 1 diabetes study of islet cell transplantation without immunosuppression.</li>
<li>Vir Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIR#NASDAQ">VIR</a>) gained 64% to $12.97 after the company announced it&#8217;s presenting initial Phase 1 data from its two dual-masked T-cell engagers (TCEs): VIR-5818 and VIR-5500.</li>
<li>AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) surged 25% to $11.74 after the company reported better-than-expected second-quarter financial results and raised its FY25 adjusted EPS guidance.</li>
<li>Absci Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>) rose 17% to $3.5900 after the company announced a strategic collaboration with AMD.</li>
<li>eBay Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) surged 11.5% to $70.44 after Meta announced a test in Germany, France and the US that will allow buyers to browse eBay listings directly on Facebook Marketplace.</li>
<li>Matthews International Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATW#NASDAQ">MATW</a>) gained 10.2% to $29.87 as the company agreed to sell SGK Brand Solutions.</li>
<li>Arcadium Lithium plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTM#NASDAQ">ALTM</a>) rose 8.6% to $5.72 after the company announced it secured CFIUS clearance regarding Rio Tinto&#8217;s proposed acquisition.</li>
<li>Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) gained 7.1% to $111.00 as the company posted better-than-expected results for its second quarter. The company said it set a quarterly record for total dozens sold and specialty dozens sold. It also announced a cash dividend of approximately $1.49 per share.</li>
<li>ADTRAN Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTN#NASDAQ">ADTN</a>) rose 6.3% to $10.25.</li>
<li>Boston Scientific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) gained 4.6% to $96.24 after the company announced it entered into a definitive deal to acquire Bold Medical.</li>
<li>UniFirst Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNF#NYSE">UNF</a>) gained 3.7% to $212.25 following upbeat quarterly earnings.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/42873668/jim-cramer-lemonade-is-up-too-much-this-health-care-stock-can-go-lower">Jim Cramer: Lemonade Is &#8216;Up Too Much,&#8217; This Health Care Stock Can Go Lower</a></li>
</ul>

Intraday Update

Movers

ABSI

ADTN

ALTM

ANGO

EBAY

MATW

SANA

AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday

U.S. stock futures advanced on Wednesday after closing lower on Tuesday. Futures of all four major indices rose in premarket trade.
After a mixed close on Monday and a fall on Tuesday, the U.S. market has remained sluggish in yet another truncated week as it will remain closed for former President Jimmy Carter&#8217;s &#8216;National Day of Mourning&#8217; on Thursday, Jan. 9.
The 10-year and two-year Treasury notes yielded 4.67% and 4.28%, respectively. The probability of having no change in the interest rates for the upcoming Jan. 31, 2025, FOMC meeting was at 95.2%, <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">according to</a> CME Group&#8217;s FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.38%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.30%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.24%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.11%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Wednesday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was up 0.33% to $590.60&nbsp;and the Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.36% to $517.02, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
U.S. stocks experienced a <a href="https://www.benzinga.com/25/01/42867409/sp-500-down-over-1-amid-decline-in-nvidia-fear-greed-index-remains-in-fear-zone">downturn </a>on Tuesday, with the S&amp;P 500 closing more than 1% lower. This decline was primarily driven by a decline in major technology companies.
Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares retreated significantly after reaching a new peak. Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) stock faced a setback following a downgrade by BofA Securities. Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) also saw a decline in its share price.
Economic data released on Tuesday showed a widening of the U.S. trade deficit. Imports increased at a faster pace than exports, contributing to the deficit.
Most sectors within the S&amp;P 500 ended the day in negative territory. Consumer discretionary, communication services and information technology were among the hardest hit. However, energy and healthcare sectors bucked the trend and closed higher.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-1.89%</td>
<td>19,489.68</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.11%</td>
<td>5,909.03</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.42%</td>
<td>42,528.36</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.74%</td>
<td>2,249.80</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
Talking about Donald Trump&#8216;s policy agenda, Christopher Wood from Jefferies wrote in his GREED &amp; Fear note dated Jan. 2 that it&#8217;s clear that certain aspects of Trump&#8217;s policy, such as the proposed tariffs and the crackdown on immigration could be inherently inflationary, something the Federal Reserve is likely aware of.
According to the note, there is a fundamental contradiction between the expectations of a disinflationary, productivity-driven boom fueled by AI and deregulation, which the U.S. stock market has been celebrating since the presidential election, and the potential economic impact of tariffs and immigration restrictions.
Regarding the latter, even if mass deportations do not occur, as is GREED &amp; Fear's base case, a substantial reduction in new arrivals could still lead to stagflationary effects.
According to the chief market strategist at Carson Research, Ryan Detrick an average year sees gains of 9.5%. This jumps to 10.6% after a 20% gain, &#8220;Suggesting better than average returns,&#8221; he said in a <a href="https://www.carsongroup.com/insights/blog/what-happens-after-stocks-gain-20/">note </a>dated Jan. 7. 
&#8220;The bull very well might have a little more up his sleeves this year. But taking this one step further shows that after back-to-back 20% gains, the next year is up 20% on average and never lower,&#8221; he added.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="961" height="463" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08050221/RYAN-DETRICK-IMAGE.png" alt="" class="wp-image-723523" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08050221/RYAN-DETRICK-IMAGE.png 961w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08050221/RYAN-DETRICK-IMAGE-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08050221/RYAN-DETRICK-IMAGE-768x370.png 768w" sizes="(max-width: 961px) 100vw, 961px" /></figure>
According to Charles Schwab <a href="https://international.schwab.com/story/stock-market-update-open">commentary</a>, &#8220;The month lacked a significant &#8216;Santa Claus Rally,&#8217; but investor sentiment appeared bullish, particularly at the start and end of December. Many clients appeared to close out the year by rebalancing their portfolios, adding exposure to underperforming sectors such as health care and energy and trimming positions in outperformers like information technology and communication services.&#8221; &#8211;
Louis Navellier of Navellier &amp; Associates said that there&#8217;s no reason to be overly concerned by the recent volatility; the trend remains positive.
&#8220;If interest rates are up because the economy is strong, that will be good for earnings growth, which will outshine any small increments in financing costs. And global market yields will likely tie the Fed's hands from being too restrictive anyway,&#8221; he added.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a>
Upcoming Economic Data
Several important data points will be released in this truncated week that will help investors determine the future course of action.
<ul>
<li>On Wednesday, December&#8217;s ADP employment data will be released at 8:15 a.m., ET.</li>
</ul>
<ul>
<li>The minutes of the Fed&#8217;s December FOMC meeting will be released at 2:00 p.m., ET.</li>
</ul>
<ul>
<li>Consumer credit data for December will be announced at 3:00 p.m., ET.</li>
</ul>
<ul>
<li>On Thursday, initial jobless claims till Jan. 4 will be announced at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>Wholesale inventories data for November will be released at 10:00 a.m., ET.</li>
</ul>
<ul>
<li>On Friday, the U.S. employment report, unemployment rate, and hourly wages data for December along with hourly wages year over year will be released at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>The preliminary consumer sentiment data for January will be announced at 10:00 a.m., ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Cal-Maine Foods Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) was up 3.78% in premarket on Wednesday after it posted better-than-expected results for its second quarter. The company said it set a quarterly record for total dozens sold and specialty dozens sold. It also announced a cash dividend of approximately $1.49 per share.</li>
</ul>
<ul>
<li>Acuity Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) was up 2.35% in premarket as analysts expect it to post quarterly earnings at $3.89 per share on revenue of $956.18 million. The company will release earnings before the markets open.</li>
</ul>
<ul>
<li>AAR Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) was up 2.36% in premarket after it posted stronger-than-expected second-quarter results. The company reported quarterly earnings of 90 cents per share, which beat the analyst consensus estimate of 84 cents.</li>
</ul>
<ul>
<li>Fubotv Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) was down 19.05% as Halper Sadeh LLC, an investor rights law firm, initiated an investigation on whether its merger with the Walt Disney Company's Hulu + Live TV business is fair to FuboTV shareholders.</li>
</ul>
<ul>
<li>Blue Hat Interactive Entertainment Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHAT#NASDAQ">BHAT</a>) was up 70.70% after it announced a $4.4 million registered direct offering of 55,200,000 Ordinary Shares.</li>
</ul>
<ul>
<li>XTI Aerospace Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTIA#NASDAQ">XTIA</a>) was down 49.08% in premarket after it announced a public offering of over 363 million shares at $0.055 per share and a 1-for-250 share consolidation as part of its 2025 strategic initiatives.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were higher in the early New York session by 1.19% to hover around $75.13 per barrel.
The gold spot index was up by 0.07% to $2,667.29 per ounce. The Dollar Index was up 0.29% to 108.858 level.
Asian markets were mostly lower on Wednesday as Hong Kong&#8217;s Hang Seng, Japan&#8217;s Nikkei 225, and China&#8217;s CSI 300 index declined. Whereas, Australia&#8217;s ASX 200, South Korea&#8217;s Kospi index ended higher. European markets were mostly higher in trade.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/01/42867184/yield-curve-normalization-cheap-valuation-eps-growth-to-boost-banks-in-2025-truist-initiates-coverage-on-these-14-regional-names">Yield Curve Normalization, Cheap Valuation, EPS Growth To Boost Banks In 2025: Truist Initiates Coverage On These 14 Regional Names</a></li>
</ul>
Photo courtesy: Wikimedia

Market Summary

Futures

Federal Reserve

BHAT

FUBO

NVDA

TSLA

XTIA

US Stocks To Open Higher As Futures Advance: Christopher Wood Expects Trump's Inflationary Policies To Hurt Market

Shares of Cal-Maine Foods Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) rose sharply in today's pre-market trading after the company posted better-than-expected <a href="https://www.benzinga.com/news/earnings/25/01/42862269/cal-maine-foods-stock-climbs-after-strong-q2-results-eps-beat-revenues-beat">results for its second quarter</a>.
The company said it set a quarterly record for total dozens sold and specialty dozens sold. It also announced a cash dividend of approximately $1.49 per share..
Cal-Maine shares jumped 3.8% to $107.60 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Sana Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>) gained 220.6% to $5.29 in pre-market trading after the company announced positive clinical trial results from its type 1 diabetes study of islet cell transplantation without immunosuppression.</li>
<li>EON Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EONR#NYSE">EONR</a>) gained 144.6% to $1.96 in pre-market trading after surging 13% on Tuesday.</li>
<li>Blue Hat Interactive Entertainment Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHAT#NASDAQ">BHAT</a>) rose 69.9% to $0.1954 in pre-market trading after jumping 28% on Tuesday.</li>
<li>JBDI Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBDI#NASDAQ">JBDI</a>) rose 68.1% to $1.19 in pre-market trading.</li>
<li>Conduit Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) rose 35.1% to $0.1270 in pre-market trading after jumping 30% on Tuesday.</li>
<li>Solid Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDB#NASDAQ">SLDB</a>) gained 22.7% to $4.81 in pre-market trading after the company announced FDA clearance of its IND application for a dual-route gene therapy to treat Friedreich&#8217;s Ataxia.</li>
<li>Graphex Group Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRFX#NYSE">GRFX</a>) gained 23.3% to $0.37 in pre-market trading after falling 13% on Tuesday.</li>
<li>SRM Entertainment, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) gained 21.2% to $0.83 in pre-market trading.</li>
<li>Bowman Consulting Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWMN#NASDAQ">BWMN</a>) gained 12.2% to $27.99 in pre-market trading. Bowman secured a $1.5 million contract with Nebraska DOT for on-call engineering services.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>XTI Aerospace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTIA#NASDAQ">XTIA</a>) fell 49.1% to $0.0581 in pre-market trading. XTI Aerospace priced its $20 million offering of 363,636,364 shares of common stock at a price of $0.055 per share.</li>
<li>DatChat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DATS#NASDAQ">DATS</a>) fell 30.5% to $6.19 in pre-market trading after jumping around 356% on Tuesday.</li>
<li>DarioHealth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRIO#NASDAQ">DRIO</a>) shares fell 28.1% to $1.10 in pre-market trading after surging 85% on Tuesday.</li>
<li>Algorhythm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) fell 26% to $0.1680 in today's pre-market trading after climbing 57% on Tuesday.</li>
<li>American Rebel Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) fell 24.7% to $2.10 in pre-market trading after jumping around 42% on Tuesday.</li>
<li>SRIVARU Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVMH#NASDAQ">SVMH</a>) dipped 23.8% to $0.0640 in pre-market trading after jumping 81% on Tuesday.</li>
<li>AmpliTech Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPG#NASDAQ">AMPG</a>) shares fell 23.1% to $2.79 in pre-market trading after dipping 9% on Tuesday.</li>
<li>Hoth Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOTH#NASDAQ">HOTH</a>) shares tumbled 22.4% to $1.77 in pre-market trading. Hoth Therapeutics shares jumped 178% on Tuesday after the company announced safety results from its Phase 2a trial, showing that 100% of patients in Cohort 1 achieved the primary efficacy endpoint.</li>
<li>SEALSQ Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>) shares dipped 19.9% to $5.73 in pre-market trading after declining around 8% on Tuesday.</li>
<li>Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) declined 17.9% to $15.10 in pre-market trading after dipping more than 5% on Tuesday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42846607/bank-of-new-york-mellon-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Bank of New York Mellon Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

AMPG

AREB

BWMN

DATS

DRIO

EONR

GRFX

HOTH

JBDI

LAES

RGTI

RIME

SLDB

SVMH

Why Cal-Maine Foods Shares Are Trading Higher By 4%; Here Are 20 Stocks Moving Premarket

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects UniFirst Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNF#NYSE">UNF</a>) to report quarterly earnings at $2.22 per share on revenue of $606.62 million before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. UniFirst shares gained 2.5% to $209.76 in after-hours trading.</li>
<li>Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) posted better-than-expected results for its second quarter. The company said it set a quarterly record for total dozens sold and specialty dozens sold. It also announced a cash dividend of approximately $1.49 per share. Cal-Maine shares climbed 3.8% to $107.60 in the after-hours trading session.</li>
<li>Analysts are expecting Acuity Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) to post quarterly earnings at $3.89 per share on revenue of $956.18 million. The company will release earnings before the markets open. Acuity Brands shares fell 0.3% to $303.00 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>AAR Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) posted stronger-than-expected second-quarter results. The company reported quarterly earnings of 90 cents per share, which beat the analyst consensus estimate of 84 cents. Quarterly revenue came in at $686.1 million, which beat the analyst consensus estimate of $654.18 million. AAR shares surged 5.8% to $65.35 in the after-hours trading session.</li>
<li>Analysts expect PriceSmart, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSMT#NASDAQ">PSMT</a>) to post quarterly earnings at $3.68 per share on revenue of $751.49 million after the closing bell. PriceSmart shares gained 0.6% to close at $92.22 on Tuesday.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42846607/bank-of-new-york-mellon-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Bank of New York Mellon Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>
Photo courtesy: Shutterstock

PSMT

UniFirst, Acuity Brands And 3 Stocks To Watch Heading Into Wednesday

Cal-Maine Foods Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) reported its second-quarter financial results after Tuesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/25/01/b42861058/cal-maine-foods-reports-results-for-second-quarter-fiscal-2025">details from the report. </a>
The Details:&nbsp;Cal-Maine Foods&nbsp;reported quarterly GAAP earnings of&nbsp;$4.47 per share, beating the&nbsp;$4.25 analyst consensus estimate. Quarterly revenue came in at $954.7 million, beating the&nbsp;$751.49 million consensus estimate. 
The company said it set a quarterly record for total dozens sold and specialty dozens sold. It also announced a cash dividend of approximately $1.49 per share.
Read Next: <a href="https://www.benzinga.com/25/01/42821300/biden-set-to-ban-future-offshore-oil-drilling-4-stocks-to-watch">Biden Set To Ban Future Offshore Oil Drilling: 4 Stocks, 2 ETFs To Watch</a>
&#8220;Cal-Maine Foods delivered a very strong financial and operating performance in the second quarter of fiscal 2025. Robust demand for shell eggs resulted in a significant increase in dozens sold for the quarter, which included the seasonal boost leading up to the Thanksgiving holiday and sales from our latest acquisition completed in June,&#8221; said Sherman Miller, CEO of Cal-Maine Foods. 
CALM Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Cal-Maine Foods shares are up 4.76% after hours at $108.61 Tuesday. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/25/01/42834240/kevin-oleary-joins-the-peoples-bid-for-tiktok-as-pending-ban-looms">Kevin O&#8217;Leary Joins The People&#8217;s Bid For TikTok As Pending Ban Looms</a>&nbsp;</li>
</ul>
Image: Courtesy of Cal-Maine Foods, Inc.

Earnings

After-Hours Center

Cal-Maine Foods Stock Climbs After Strong Q2 Results: EPS Beat, Revenues Beat

Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) released its Q2 earnings on Tuesday, January 7, 2025 at 04:05 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
Cal-Maine Foods beat estimated earnings by 21.0%, reporting an EPS of $4.47 versus an estimate of $3.68.
Revenue was up $431.44 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
The company beat on EPS by $0.73 in the last quarter, resulting in a 2.0% drop share price change the following day.
Here's a look at Cal-Maine Foods's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.33</td>
<td>1.85</td>
<td>2.46</td>
<td>0.83</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>3.06</td>
<td>2.32</td>
<td>3</td>
<td>0.65</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>614.77M</td>
<td>608.66M</td>
<td>692.35M</td>
<td>525.39M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>785.87M</td>
<td>640.79M</td>
<td>703.08M</td>
<td>523.23M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Cal-Maine Foods <a href="https://www.benzinga.com/quote/CALM/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cal-Maine Foods Earnings Report: Q2 Overview

Cal-Maine Foods shares are trading higher after the company reported better-than-expected Q2 EPS and revenues.

Press Releases

Cal-Maine Foods, Inc. Names Judd Stevens Vice President, Operations

Opinion

Rising Food Costs and Supply Chain Strains: How Agritech Companies Are Responding

Cal-Maine Foods, Inc. Announces Strategic Investment in New Egg Products Joint Venture

Cal-Maine Foods, Inc. Announces Release Date for First Quarter Fiscal 2025 Results

Cal-Maine Foods Reports Results for First Quarter Fiscal 2025

Cal-Maine Foods, Inc. Announces Expansion Plans for Additional Cage-Free Production Capabilities

Cal-Maine Foods, Inc. to Participate in Stephens 2024 Annual Investment Conference

Cal-Maine Foods, Inc. Announces Release Date for Second Quarter Fiscal 2025 Results

Cal-Maine Foods Reports Results for Second Quarter Fiscal 2025

Cal-Maine Foods, Inc. Announces Acquisition of Feed Mill Operations in North Carolina

BEVVF

CSE:BEE

CVGW

Conagra Brands

Campbell`s

Flowers Foods

Freshpet

General Mills

Hormel Foods

Hershey

J&J Snack Foods

Kellanova

Kraft Heinz

Lancaster Colony Corporation - Common Stock

Lancaster Colony

Lamb Weston Hldgs

Mondelez International, Inc. - Class A Common Stock

Mondelez International

McCormick & Company, Incorporated Common Stock

McCormick & Co

Nomad Foods

Oatly Group AB - American Depositary Shares

Oatly Group

Post Holdings

Pilgrim's Pride Corporation - Common Stock

Pilgrims Pride

Seaboard

Smithfield Foods

JM Smucker

The Simply Good Foods Company - Common Stock

Simply Good Foods

Tyson Foods

Stephens & Co.

Goldman Sachs

Cal-Maine Foods, Inc.

Comments

Cal-Maine Foods

空売り

Cal-Maine Foods (NASDAQ:CALM) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル